Rational Combinations 360°

Memo

Rational Combinations 360° provided the most up-to-date research, data and progress on combination developments to help IO stakeholders:



- Be at the forefront of the most relevant research and developments for IO combinations from key leadership who are at the pulse of cancer immunotherapy

- Foster collaboration amongst others working in all aspects of cancer immunotherapy by rounding up all stakeholders under one roof

- Receive the latest pre-clinical, translational and clinical data from academia and industry

- Better understand what assets are available for potential combinations that may be able to give patients more treatment options

- Create and prioritize combination strategies targeted toward specific tumor types

- Get key investor and analyst evaluations and insights on the IO combination landscape

- Learn about biomarker advancements, neoantigen approaches and more

- Obtain coverage on a wide range of emerging technologies



The Rational Combinations 360° is a comprehensive program providing exposure to the entire spectrum of RandD, addressing key aspects across all facets of combination immunotherapies including:



- Discovery / Preclinical Science

- Translational Science

- Clinical Operations and Development

- Business Aspects

- Financial and Commercial Implications

- Emerging Technologies

- Biomarkers and Diagnostics

- Trends in the Field



Understanding and determining how to apply certain IO combinations for the right patients and specific tumor types is arguably the most difficult challenge within cancer immunotherapy.



URLs:

Booking: https://go.evvnt.com/214481-0?pid=5569

Tickets: https://go.evvnt.com/214481-2?pid=5569



Time: 08:00 am to 06:00 pm.



Venue details: Wyndham Philadelphia Historic District, 400 Arch Street, Philadelphia, 19106, United States.





Prices:

Pharma and Biotech standard rate: USD 1895.0,

Standard Industry standard rate: USD 1895.0,

Academia, Non-Profit and Government standard rate: USD 947.5.



Speakers: Ohad Amit, PhD, Roy Baynes, MD, PhD, Jeffrey Bockman, PhD, Marcus Bosenberg, MD, PhD, Amanda Bruno, PhD, Lauren Byers, MD, Daniel Chen, MD, PhD, Jonathan Fassberg, David Giljohann, PhD, Lindee Goh, PhD, Asthika Goonewardene, Philip Gotwals, PhD, Carol Haddad, , Axel Hoos, MD, PhD, Patrick Hwu, MD, Dirk Jäeger, MD, Maria Jure-Kunkel, PhD, Michael Kalos, PhD, Michael King Jr, Theresa LaVallee, PhD, Ke Liu, MD, PhD, Roger Longman, Jason Luke, MD, Ian McCaffery, PhD, Erin Newburn, PhD, Mark Paris, PhD, Steven Rosenberg, MD, PhD, Ruth Rutledge, Mark A Socinski, MD, Jennifer Wargo, MD, Lei Zheng, MD, PhD